search

Pfizer-BioNTech to test combined COVID and flu vaccine

Illustrative image: A health worker prepares a Pfizer COVID-19 vaccine at a vaccination clinic in Chester, Pennsylvania, on Dec. 15, 2021.  (AP Photo/Matt Rourke, File)
Illustrative image: A health worker prepares a Pfizer COVID-19 vaccine at a vaccination clinic in Chester, Pennsylvania, on Dec. 15, 2021. (AP Photo/Matt Rourke, File)

Pfizer-BioNTech says it will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.

The two partner companies say in a statement the mRNA-based combination vaccine candidate is set to progress to a phase one trial in the United States with 180 volunteers.

The inoculation “could simplify immunization practices against these two respiratory pathogens, potentially leading to better vaccine uptake for both diseases,” says Annaliesa Anderson, head of vaccine research and development at US drugmaker Pfizer.

“Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world, causing thousands of deaths and hospitalizations every year.”

Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.